Imc Chicago, LLC Clovis Oncology, Inc. Transaction History

Imc Chicago, LLC

  • $3.02 Billion
  • Q3 2024

A detailed history of Imc Chicago, LLC transactions in Clovis Oncology, Inc. stock. As of the latest transaction made, Imc Chicago, LLC holds 103,900 shares of CLVS stock, worth $9,351. This represents 0.0% of its overall portfolio holdings.

Number of Shares
103,900
Holding current value
$9,351
% of portfolio
0.0%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
No transaction found.

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Imc Chicago, LLC Portfolio

Follow Imc Chicago, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Imc Chicago, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email